Sec. 605. REVIEW OF THE BENEFITS OF GENOMIC ENGINEERING TECHNOLOGIES AND THEIR POTENTIAL ROLE IN NATIONAL SECURITY
452 words·~2 min read·
/statute-compilations/comps-15494/sec-605A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 605 REVIEW OF THE BENEFITS OF GENOMIC ENGINEERING TECHNOLOGIES AND THEIR POTENTIAL ROLE IN NATIONAL SECURITY ###
(a)Meeting ####
(1)In general Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the “Secretary”) shall convene a meeting to discuss the potential role advancements in genomic engineering technologies (including genome editing technologies) may have in advancing national health security. Such meeting shall be held in a manner that does not compromise national security. ####
(2)Attendees The attendees of the meeting under paragraph (1)— #####
(A)shall include— ######
(i)representatives from the Office of the Assistant Secretary for Preparedness and Response, the National Institutes of Health, the Centers for Disease Control and Prevention, and the Food and Drug Administration; and ######
(ii)representatives from academic, private, and nonprofit entities with expertise in genome engineering technologies, biopharmaceuticals, medicine, or biodefense, and other relevant stakeholders; and #####
(B)may include— ######
(i)other representatives from the Department of Health and Human Services, as the Secretary determines appropriate; and ######
(ii)representatives from the Department of Homeland Security, the Department of Defense, the Department of Agriculture, and other departments, as the Secretary may request for the meeting. ####
(3)Topics The meeting under paragraph
(1)shall include a discussion of— #####
(A)the current state of the science of genomic engineering technologies related to national health security, including— ######
(i)medical countermeasure development, including potential efficiencies in the development pathway and detection technologies; and ######
(ii)the international and domestic regulation of products utilizing genome editing technologies; and #####
(B)national security implications, including— ######
(i)capabilities of the United States to leverage genomic engineering technologies as a part of the medical countermeasure enterprise, including current applicable research, development, and application efforts underway within the Department of Defense; ######
(ii)the potential for state and non-state actors to utilize genomic engineering technologies as a national health security threat; and ######
(iii)security measures to monitor and assess the potential threat that may result from utilization of genomic engineering technologies and related technologies for the purpose of compromising national health security. ###
(b)Report Not later than 270 days after the meeting described in subsection
(a)is held, the Assistant Secretary for Preparedness and Response shall issue a report to the congressional committees of jurisdiction on the topics discussed at such meeting, and provide recommendations, as applicable, to utilize innovations in genomic engineering (including genome editing) and related technologies as a part of preparedness and response activities to advance national health security. Such report shall be issued in a manner that does not compromise national security.